1. Home
  2. RNP vs SPTX Comparison

RNP vs SPTX Comparison

Compare RNP & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers REIT and Preferred and Income Fund Inc.

RNP

Cohen & Steers REIT and Preferred and Income Fund Inc.

N/A

Current Price

$18.52

Market Cap

984.5M

Sector

Finance

ML Signal

N/A

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$18.60

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RNP
SPTX
Founded
2003
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
984.5M
1.2B
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
RNP
SPTX
Price
$18.52
$18.60
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $38.29
AVG Volume (30 Days)
109.1K
★ 155.6K
Earning Date
01-01-0001
11-05-2026
Dividend Yield
★ 7.94%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.64
$17.59
52 Week High
$22.33
$28.38

Technical Indicators

Market Signals
Indicator
RNP
SPTX
Relative Strength Index (RSI) 23.27 44.86
Support Level N/A $18.72
Resistance Level $20.97 $22.75
Average True Range (ATR) 0.24 1.81
MACD -0.06 -0.26
Stochastic Oscillator 0.00 32.71

Price Performance

Historical Comparison
RNP
SPTX

About RNP Cohen & Steers REIT and Preferred and Income Fund Inc.

Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances. The Fund seeks to achieve its objectives through a portfolio of income producing common stock issued by REITs and preferred and other debt securities.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: